Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Diseases

Free Subscription Articles published in Am J Gastroenterol Retrieve available abstracts of 241 articles: HTML format

Single Articles

April 2024
1. HUME SJ, Holmes JA, Thompson AJ
   Individualizing the Approach to Stopping Nucleos(t)ide Analogs: Can We Use a Low HBsAg Threshold to Predict a High Chance of Functional Cure and Minimal Risk of Hepatic Decompensation?
   Am J Gastroenterol. 2024 Apr 15. doi: 10.14309/ajg.0000000000002766.
   PubMed    
   
   
   
2. ERMINELLI D, Mangini C, Zarantonello L, Angeli P, et al
   Overt hepatic encephalopathy - more than meets the eye.
   Am J Gastroenterol. 2024 Apr 8. doi: 10.14309/ajg.0000000000002795.
   PubMed     Abstract available
   
   
   
3. KHANNA S, Shah NL, Argo CK
   Use of Phosphatidylethanol Testing in Patients With Liver Disease.
   Am J Gastroenterol. 2024;119:596-599.
   PubMed    
   
   
   
4. PERUMALSWAMI PV, Winder GS, Fernandez AC, Mellinger JL, et al
   Practical Considerations to Optimize Care for Patients With Alcohol-Associated Liver Disease in General Gastroenterology Practice.
   Am J Gastroenterol. 2024;119:591-595.
   PubMed    
   
   
   March 2024
5. CHEN YT, Chen TI, Yang TH, Yin SC, et al
   Long-term Risks for Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes.
   Am J Gastroenterol. 2024 Mar 27. doi: 10.14309/ajg.0000000000002778.
   PubMed     Abstract available
   
   
   
6. CHEN QF, Chen S, Yi JZ, Wang JL, et al
   Recommended Ten Years' Follow-Up Strategy for Small Hepatocellular Carcinoma after Radiofrequency Ablation: A Cost-Effectiveness Evaluation.
   Am J Gastroenterol. 2024 Mar 25. doi: 10.14309/ajg.0000000000002774.
   PubMed     Abstract available
   
   
   
7. LO GH, Yeh JH, Tseng CH, Chen TH, et al
   A non-inferiority trial comparing 2 days vs. 5 days of terlipressin and ceftriaxone in terms of 5-day rebleeding for patients with acute gastro-esophageal variceal hemorrhage.
   Am J Gastroenterol. 2024 Mar 25. doi: 10.14309/ajg.0000000000002776.
   PubMed     Abstract available
   
   
   
8. TABISH M, Agarwal S, Gopi S, Rana R, et al
   Randomized controlled trial of Intravenous ferric-carboxymaltose vs oral iron to treat iron deficiency anemia after variceal bleed in patients with cirrhosis.
   Am J Gastroenterol. 2024 Mar 22. doi: 10.14309/ajg.0000000000002775.
   PubMed     Abstract available
   
   
   
9. SAMALA N, Xin Y, Wilson LA, Yates K, et al
   Non-Hispanic Black persons with nonalcoholic fatty liver disease have lower rates of advanced fibrosis, cirrhosis, and liver-related events even after controlling for clinical risk factors and PNPLA3 genotype.
   Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002756.
   PubMed     Abstract available
   
   
   
10. HIRODE G, Hansen BE, Chen CH, Su TH, et al
    Erratum: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
    Am J Gastroenterol. 2024 Mar 8. doi: 10.14309/ajg.0000000000002718.
    PubMed    
    
    
    February 2024
11. SASAKI S, Schmidt S, Uldry E, Halkic N, et al
    Hepaticocholecystic Duct: Not a Myth but a Pitfall in Cholecystectomy.
    Am J Gastroenterol. 2024 Feb 19. doi: 10.14309/ajg.0000000000002725.
    PubMed    
    
    
    
12. LOUISSAINT J, Vargas HE
    Picture Perfect: Artificial Intelligence in the Management of Hepatic Encephalopathy.
    Am J Gastroenterol. 2024 Feb 16. doi: 10.14309/ajg.0000000000002659.
    PubMed    
    
    
    
13. BUI H, Kumar NG, Singal AG, Boparai J, et al
    Implementation of a hepatocellular carcinoma surveillance program in a community-based integrated health system in patients with hepatitis C cirrhosis.
    Am J Gastroenterol. 2024 Feb 9. doi: 10.14309/ajg.0000000000002704.
    PubMed     Abstract available
    
    
    
14. RANGRAY R
    Continuing Medical Education Questions: February 2024.
    Am J Gastroenterol. 2024;119:248.
    PubMed     Abstract available
    
    
    
15. BATHEJA MA
    Continuing Medical Education Questions: February 2024.
    Am J Gastroenterol. 2024;119:247.
    PubMed     Abstract available
    
    
    
16. MURPHY CC, Tavakkoli A, Wani S, Singal AG, et al
    Pandemic-Related Changes in Incidence and Mortality Rates of Gastrointestinal Cancers During 2020.
    Am J Gastroenterol. 2024;119:382-387.
    PubMed     Abstract available
    
    
    
17. JULIEN J, Ayer T, Tapper EB, Chhatwal J, et al
    The Rising Costs of Alcohol-Associated Liver Disease in the United States.
    Am J Gastroenterol. 2024;119:270-277.
    PubMed     Abstract available
    
    
    January 2024
18. GE J, Chen IY, Pletcher MJ, Lai JC, et al
    How I Approach It: Prompt Engineering for Generative Artificial Intelligence (GAI) in Gastroenterology and Hepatology.
    Am J Gastroenterol. 2024 Jan 31. doi: 10.14309/ajg.0000000000002689.
    PubMed    
    
    
    
19. CHARA BS, Hara KS, Penrice D, Schmidt KA, et al
    ARTIFICIAL INTELLIGENCE-ENABLED STOOL ANALYSIS FOR LACTULOSE TITRATION ASSISTANCE IN HEPATIC ENCEPHALOPATHY VIA A SMARTPHONE APPLICATION.
    Am J Gastroenterol. 2024 Jan 19. doi: 10.14309/ajg.0000000000002656.
    PubMed     Abstract available
    
    
    
20. BLOOM PP, Bajaj JS
    The Current and Future State of Microbiome Therapeutics in Liver Disease.
    Am J Gastroenterol. 2024;119.
    PubMed    
    
    
    
21. KARNA R
    Continuing Medical Education Questions: January 2024.
    Am J Gastroenterol. 2024;119:27.
    PubMed     Abstract available
    
    
    
22. NICOLETTI P, Dellinger A, Li YJ, Barnhart H, et al
    HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans.
    Am J Gastroenterol. 2024;119:200-202.
    PubMed     Abstract available
    
    
    December 2023
23. FAGAN A, Gallagher ML, Mousel T, Davis BC, et al
    AI evaluation of Stool Quality Guides Management of Hepatic Encephalopathy using a Smartphone App.
    Am J Gastroenterol. 2023 Dec 28. doi: 10.14309/ajg.0000000000002646.
    PubMed     Abstract available
    
    
    
24. MUI BG, Grinspan LT, Crismale JF
    Variations in practice among cirrhotic patients with portal vein thrombosis and esophageal varices: a North American survey study.
    Am J Gastroenterol. 2023 Dec 26. doi: 10.14309/ajg.0000000000002640.
    PubMed     Abstract available
    
    
    
25. MULGAONKAR A, Huang DQ, Siddiqi H, Fowler K, et al
    Cost-Effectiveness Analysis of HCC Surveillance in Nonalcoholic Fatty Liver Disease Cirrhosis using US Visualization Score C-Triggered Abbreviated MRI.
    Am J Gastroenterol. 2023 Dec 26. doi: 10.14309/ajg.0000000000002636.
    PubMed     Abstract available
    
    
    
26. PRICE JC, Springer G, Seaberg EC, Budoff MJ, et al
    High incidence rate of CT-measured steatotic liver disease in men with and without HIV infection.
    Am J Gastroenterol. 2023 Dec 22. doi: 10.14309/ajg.0000000000002633.
    PubMed     Abstract available
    
    
    
27. LEE JD, Gounko D, Lee JA, Mukherjee T, et al
    Assisted Reproductive Technology Treatment Outcomes in Women With Liver Disease.
    Am J Gastroenterol. 2023;118:2184-2190.
    PubMed     Abstract available
    
    
    November 2023
28. DAHER D, El Dahan KS, Yekkaluri S, Gopal P, et al
    Proportion Time Covered by Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002596.
    PubMed     Abstract available
    
    
    
29. HASHMI I, Chadha N, McIntosh G, Sterling R, et al
    Quality Improvement for Health Care Providers in Gastroenterology and Hepatology.
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002609.
    PubMed    
    
    
    
30. KULKARNI AV, Avadhanam M, Karandikar P, Rakam K, et al
    Antibiotics with or without Rifaximin for acute hepatic Encephalopathy in critically ill patients with cirrhosis: A double-blind, randomized controlled (ARiE) trial.
    Am J Gastroenterol. 2023 Nov 9. doi: 10.14309/ajg.0000000000002575.
    PubMed     Abstract available
    
    
    
31. BAJAJ JS, Kamath PS, Reddy KR, Asrani SK, et al
    Predictors of Respiratory Failure Development in A Multi-Center Cohort of Inpatients with Cirrhosis.
    Am J Gastroenterol. 2023 Nov 8. doi: 10.14309/ajg.0000000000002574.
    PubMed     Abstract available
    
    
    
32. PATEL A, Bowman CA, Prause N, Kilaru SM, et al
    Outcomes of a Three-Year Quality Improvement Study to Improve Advance Care Planning in Patients with Decompensated Cirrhosis.
    Am J Gastroenterol. 2023 Nov 7. doi: 10.14309/ajg.0000000000002570.
    PubMed     Abstract available
    
    
    
33. WANG B, Zhou J, Wu X, Sun Y, et al
    Carvedilol plus NUCs for compensated HBV-cirrhosis patients under virological suppression: a randomised, open-label trial.
    Am J Gastroenterol. 2023 Nov 6. doi: 10.14309/ajg.0000000000002569.
    PubMed     Abstract available
    
    
    
34. YAGHOOBI M
    Continuing Medical Education Questions: November 2023.
    Am J Gastroenterol. 2023;118:1925.
    PubMed     Abstract available
    
    
    
35. KIM J, Zhang Y, Kim H, Zhang Y, et al
    A Comparative Study of Healthy Dietary Patterns for Incident and Fatal Digestive System Cancer.
    Am J Gastroenterol. 2023;118:2061-2070.
    PubMed     Abstract available
    
    
    
36. SQUIZZATO F, Abruzzino G, Piazza M
    Acute Liver Failure in a Patient With Previous Vascular Surgery for Bowel Ischemia.
    Am J Gastroenterol. 2023;118:1919.
    PubMed    
    
    
    
37. CHO Y, Chang Y, Ryu S, Kim C, et al
    History of Gestational Diabetes and Incident Nonalcoholic Fatty Liver Disease: The Kangbuk Samsung Health Study.
    Am J Gastroenterol. 2023;118:1980-1988.
    PubMed     Abstract available
    
    
    October 2023
38. LV XH, Lu Q, Deng K, Yang JL, et al
    Prevalence and characteristics of covert/minimal hepatic encephalopathy in patients with liver cirrhosis: A systematic review and meta-analysis.
    Am J Gastroenterol. 2023 Oct 19. doi: 10.14309/ajg.0000000000002563.
    PubMed     Abstract available
    
    
    
39. SILKE L, Donata G, Dominik G, Uli F, et al
    Endoscopic features of post-COVID-19 cholangiopathy and its management using ERCP.
    Am J Gastroenterol. 2023 Oct 16. doi: 10.14309/ajg.0000000000002562.
    PubMed     Abstract available
    
    
    
40. OZTURK NB, Jamil LH, Tapper EB
    Diagnostic Performance of the ICD-10 Code K76.82 for Hepatic Encephalopathy in Patients with Cirrhosis.
    Am J Gastroenterol. 2023 Oct 13. doi: 10.14309/ajg.0000000000002560.
    PubMed     Abstract available
    
    
    
41. PRASOPPOKAKORN T, Panarat P
    Disseminated Melioidosis infection involving hepatosplenomegaly and massive extramedullary hematopoiesis.
    Am J Gastroenterol. 2023 Oct 4. doi: 10.14309/ajg.0000000000002549.
    PubMed    
    
    
    
42. PULASKI M, Bittermann T, Taddei TH, Kaplan DE, et al
    The Association between Homelessness and Key Liver-Related Outcomes in Veterans with Cirrhosis.
    Am J Gastroenterol. 2023 Oct 2. doi: 10.14309/ajg.0000000000002535.
    PubMed     Abstract available
    
    
    
43. ONG J, Mandour MO, Allison M
    Endoscopic Gastric Plication in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2023;118:1899.
    PubMed    
    
    
    September 2023
44. NACHEF C, Bousson V, Belmatoug N, Cohen-Solal M, et al
    Osteoporosis and fragility fractures in patients with cirrhosis evaluated for liver transplantation: Identification of high-risk patients based on computed tomography at evaluation.
    Am J Gastroenterol. 2023 Sep 20. doi: 10.14309/ajg.0000000000002507.
    PubMed     Abstract available
    
    
    
45. FENG X, Li H, Bajaj J, Moon AM, et al
    Endoscopic Ultrasound (EUS)-guided Sclerotherapy with Lauromacrogol: A Novel Therapy for A Giant Esophageal Hemangioma.
    Am J Gastroenterol. 2023 Sep 20. doi: 10.14309/ajg.0000000000002514.
    PubMed    
    
    
    
46. ZHOU R, Zhang B, Gu Y, Li J, et al
    A Promising Digital Therapeutics for Nonalcoholic Steatohepatitis: More Efforts Are Needed.
    Am J Gastroenterol. 2023;118:1704-1705.
    PubMed    
    
    
    
47. LIAW YF
    Impact of ALT Changes on the Risk of HCC in Hepatitis B-Compensated Cirrhotic Patients With Low Viremia.
    Am J Gastroenterol. 2023;118:1701.
    PubMed    
    
    
    
48. RAMKISSOON R, Codipilly DC, Kane SV
    Gastric Outlet Obstruction From a Massive Liver Abscess.
    Am J Gastroenterol. 2023;118:1539.
    PubMed    
    
    
    
49. MEYERS MH, Rodriguez L, Kriss MS
    A Practical Approach to the Management of Gastric Antral Vascular Ectasia.
    Am J Gastroenterol. 2023;118:1532-1535.
    PubMed    
    
    
    
50. VILAR-GOMEZ E, Vuppalanchi R, Gawrieh S, Pike F, et al
    Significant Dose-Response Association of Physical Activity and Diet Quality With Mortality in Adults With Suspected NAFLD in a Population Study.
    Am J Gastroenterol. 2023;118:1576-1591.
    PubMed     Abstract available
    
    
    August 2023
51. RATHI S, Kalantri A, Shastri A, Shree R, et al
    Endoscopic Ultrasound Guided Transgastric Shunt Obliteration (ETSO) for Recurrent Hepatic Encephalopathy.
    Am J Gastroenterol. 2023 Aug 17. doi: 10.14309/ajg.0000000000002477.
    PubMed     Abstract available
    
    
    
52. KANWAL F, Nelson R, Liu Y, Kramer JR, et al
    Cost of Care for Patients with Cirrhosis.
    Am J Gastroenterol. 2023 Aug 10. doi: 10.14309/ajg.0000000000002472.
    PubMed     Abstract available
    
    
    
53. YEO YH, Liang J, Lauzon M, Luu M, et al
    Immunotherapy and Transarterial Radioembolization Combination Treatment for Advanced Hepatocellular Carcinoma.
    Am J Gastroenterol. 2023 Aug 10. doi: 10.14309/ajg.0000000000002467.
    PubMed     Abstract available
    
    
    
54. TAPPER EB, Zhao Z, Parikh ND
    An emulated clinical trial of deprescribing proton pump inhibitors in patients with cirrhosis.
    Am J Gastroenterol. 2023 Aug 10. doi: 10.14309/ajg.0000000000002462.
    PubMed     Abstract available
    
    
    
55. WANG M, Cedars MI, Mehta N, Sarkar M, et al
    How I Approach Hepatocellular Adenomas in Hormonally Distinct Populations: Time to Think Outside the (Contraceptive Pill) Box.
    Am J Gastroenterol. 2023 Aug 7. doi: 10.14309/ajg.0000000000002456.
    PubMed    
    
    
    
56. CHEN WC, Yang TC, Lee PC, Wang YP, et al
    A randomized controlled trial of propranolol use during ligation program for secondary prophylaxis of esophageal variceal bleeding.
    Am J Gastroenterol. 2023 Aug 7. doi: 10.14309/ajg.0000000000002457.
    PubMed     Abstract available
    
    
    
57. ZUO J, Wang W, Li H, Chen C, et al
    Endoscopic submucosal dissection for hypervascularized esophageal squamous cell carcinoma in decompensated cirrhosis with esophageal varices and scars.
    Am J Gastroenterol. 2023 Aug 7. doi: 10.14309/ajg.0000000000002459.
    PubMed    
    
    
    
58. ORMAN ES, Desai AP, Ghabril MS, Nephew LD, et al
    Thirty-day readmissions are largely not preventable in patients with cirrhosis.
    Am J Gastroenterol. 2023 Aug 7. doi: 10.14309/ajg.0000000000002455.
    PubMed     Abstract available
    
    
    
59. CARROLL AM, Rotman Y
    Nutrition Literacy Is Not Sufficient to Induce Needed Dietary Changes in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2023;118:1381-1387.
    PubMed     Abstract available
    
    
    July 2023
60. LARINO-NOIA J, Fernandez-Castroagudin J, de la Iglesia-Garcia D, Lazare H, et al
    Quality of Tissue Samples Obtained by Endoscopic Ultrasound-Guided Liver Biopsy: A Randomized, Controlled Clinical Trial.
    Am J Gastroenterol. 2023 Jul 14. doi: 10.14309/ajg.0000000000002375.
    PubMed     Abstract available
    
    
    
61. BALLESTER MP, Rose CF, Carbonell-Asins JA, Jalan R, et al
    Measuring and Interpreting Ammonia Levels in Cirrhosis.
    Am J Gastroenterol. 2023;118:1297.
    PubMed    
    
    
    
62. SHINGINA A, Mukhtar N, Wakim-Fleming J, Alqahtani S, et al
    Acute Liver Failure Guidelines.
    Am J Gastroenterol. 2023;118:1128-1153.
    PubMed     Abstract available
    
    
    June 2023
63. WONG F, Kwo P
    Practical Management of HRS-AKI in the Era of Terlipressin: What the Gastroenterologist Needs to Know.
    Am J Gastroenterol. 2023;118:915-920.
    PubMed    
    
    
    May 2023
64. CONSIGLIERI CF, Puigcerver-Mas M, Garcia-Sumalla A, Gornals JB, et al
    Transpapillary Stent via ERCP Combined with Hepaticoduodenostomy and Gallbladder Drainage for a Complex Hilar Malignant Obstruction.
    Am J Gastroenterol. 2023 May 22. doi: 10.14309/ajg.0000000000002336.
    PubMed    
    
    
    
65. LEAL-VILLARREAL MA, Aguirre-Villarreal D, Vidal-Mayo JJ, Argaiz ER, et al
    Correlation of internal jugular vein (IJV) collapsibility with central venous pressure (CVP) in patients with liver cirrhosis.
    Am J Gastroenterol. 2023 May 4. doi: 10.14309/ajg.0000000000002315.
    PubMed     Abstract available
    
    
    
66. JANSSON-KNODELL CL, Rubio-Tapia A
    The Liver in Celiac Disease: A Strong 2-Way Talk!
    Am J Gastroenterol. 2023;118:784-785.
    PubMed    
    
    
    
67. YOOSUF S, Singh P, Khaitan A, Strand TA, et al
    Prevalence of Celiac Disease in Patients With Liver Diseases: A Systematic Review and Meta-Analyses.
    Am J Gastroenterol. 2023;118:820-832.
    PubMed     Abstract available
    
    
    
68. ZHANG H, Jiang B, Meng ZJ
    The Neglected Portal Intrahepatic Shunts.
    Am J Gastroenterol. 2023;118:909.
    PubMed    
    
    
    April 2023
69. KUMARI S, De A, Kalra N, Singh V, et al
    Growth Hormone Therapy in Decompensated Cirrhosis: An Open-Label, Randomized Control Trial.
    Am J Gastroenterol. 2023 Apr 27. doi: 10.14309/ajg.0000000000002300.
    PubMed     Abstract available
    
    
    
70. AVADHANAM M, Kulkarni AV
    Conventional Antibiotics for Spontaneous Bacterial Peritonitis: Are They Still Effective?
    Am J Gastroenterol. 2023;118:613-614.
    PubMed    
    
    
    
71. YIM HJ, Kim TH, Suh SJ, Yim SY, et al
    Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial: A Validation Study of 2021 AASLD Practice Guidance for SBP.
    Am J Gastroenterol. 2023;118:654-663.
    PubMed     Abstract available
    
    
    March 2023
72. HUANG X, Lin X, Yang S, Chen G, et al
    A rare case of an esophageal mass with varices: esophageal metastasis of hepatocellular carcinoma.
    Am J Gastroenterol. 2023 Mar 28. doi: 10.14309/ajg.0000000000002264.
    PubMed    
    
    
    
73. GAIRING SJ, Mangini C, Zarantonello L, Gioia S, et al
    Prevalence of minimal hepatic encephalopathy in patients with liver cirrhosis: a multicenter study.
    Am J Gastroenterol. 2023 Mar 20. doi: 10.14309/ajg.0000000000002251.
    PubMed     Abstract available
    
    
    
74. LOZADA MEL ME, Zhang Nz N, Jin Wj W, Wongjarupong Nw N, et al
    CS-iCCA; A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation.
    Am J Gastroenterol. 2023 Mar 20. doi: 10.14309/ajg.0000000000002258.
    PubMed     Abstract available
    
    
    
75. GHANY MG, Saraswat VA
    Patients With Compensated Hepatitis B Virus-Related Cirrhosis and Low-Level Viremia: Treat or Not to Treat?
    Am J Gastroenterol. 2023 Mar 20. doi: 10.14309/ajg.0000000000002224.
    PubMed     Abstract available
    
    
    
76. KONG X, Kong F, Liu W, Qi K, et al
    From Hepaticogastrostomy to Choledochoduodenostomy: A Rare Stent Migration after EUS-guided Hepaticogastrostomy.
    Am J Gastroenterol. 2023 Mar 9. doi: 10.14309/ajg.0000000000002240.
    PubMed    
    
    
    
77. LIU Y, Guo G, Zheng L, Sun R, et al
    Effectiveness of fenofibrate in treatment-naive patients with primary biliary cholangitis: A Randomized Clinical Trial.
    Am J Gastroenterol. 2023 Mar 9. doi: 10.14309/ajg.0000000000002238.
    PubMed     Abstract available
    
    
    
78. HAN Q, Han X, Wang X, Wang C, et al
    Association of Accelerometer-Measured Sedentary Behavior Patterns With Nonalcoholic Fatty Liver Disease Among Older Adults: The MIND-China Study.
    Am J Gastroenterol. 2023;118:569-573.
    PubMed     Abstract available
    
    
    
79. TADDEI TH, Jou JH
    When to Stop Screening-Liver Cancer.
    Am J Gastroenterol. 2023;118:427-428.
    PubMed    
    
    
    
80. ABBAS D, Fix OK, Evon DM, Barritt AS 4th, et al
    Tangible Resources for Multidisciplinary Treatment of Patients With Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2023;118:389-393.
    PubMed    
    
    
    February 2023
81. FONTANA RJ, Kleiner DE, Chalasani N, Bonkovsky H, et al
    The impact of patient age and corticosteroids in patients with Sulfonamide hepatotoxicity.
    Am J Gastroenterol. 2023 Feb 27. doi: 10.14309/ajg.0000000000002232.
    PubMed     Abstract available
    
    
    
82. BRANDT LJ
    Use of the Stethoscope to Diagnose Gastrointestinal and Hepatic Disorders.
    Am J Gastroenterol. 2023 Feb 24. doi: 10.14309/ajg.0000000000002233.
    PubMed    
    
    
    
83. N S, N S, M D, H M, et al
    Incidence of cirrhosis among recent immigrants and refugees to Ontario, Canada.
    Am J Gastroenterol. 2023 Feb 8. doi: 10.14309/ajg.0000000000002214.
    PubMed     Abstract available
    
    
    
84. JEON D, Kim YJ, Kim S, Choi WM, et al
    Liver Cirrhosis Increases the Risk of Herpes Zoster: A Nationwide Population-based Cohort Study.
    Am J Gastroenterol. 2023 Feb 3. doi: 10.14309/ajg.0000000000002209.
    PubMed     Abstract available
    
    
    
85. VUTIEN P, Li R, Karkar R, Munson SA, et al
    Evaluating a Novel, Portable, Self-Administrable Device ("Beacon") that Measures Critical Flicker Frequency as a Test for Hepatic Encephalopathy.
    Am J Gastroenterol. 2023 Feb 3. doi: 10.14309/ajg.0000000000002211.
    PubMed     Abstract available
    
    
    
86. HAYASHI M, Matsuda M, Yamadera Y, Nakamura J, et al
    Isolated Small Bowel Varices Diagnosed by Contrast-Enhanced Ultrasound.
    Am J Gastroenterol. 2023 Feb 3. doi: 10.14309/ajg.0000000000002184.
    PubMed    
    
    
    
87. MOON AM, Kim HP, Jiang Y, Lupu G, et al
    Systematic Review and Meta-Analysis on the Effects of Lactulose and Rifaximin on Patient-Reported Outcomes in Hepatic Encephalopathy.
    Am J Gastroenterol. 2023;118:284-293.
    PubMed     Abstract available
    
    
    
88. KOWDLEY KV, Bowlus CL, Levy C, Mayo MJ, et al
    Application of the Latest Advances in Evidence-Based Medicine in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2023;118:232-242.
    PubMed     Abstract available
    
    
    January 2023
89. HIRODE ASG, Hansen BE, Chen CH, Su TH, et al
    Incidence of hepatic decompensation after nucleos(t)ide analogue withdrawal: Results from a large, international, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study).
    Am J Gastroenterol. 2023 Jan 30. doi: 10.14309/ajg.0000000000002203.
    PubMed     Abstract available
    
    
    
90. STINE JG, DiJoseph K, Pattison Z, Harrington A, et al
    Exercise Training Is Associated With Treatment Response in Liver Fat Content by Magnetic Resonance Imaging Independent of Clinically Significant Body Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2023 Jan 30. doi: 10.14309/ajg.0000000000002098.
    PubMed     Abstract available
    
    
    
91. SATO M, Akamatsu M, Shima T, Ikegami T, et al
    Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The NASH App Clinical Trial.
    Am J Gastroenterol. 2023 Jan 20. doi: 10.14309/ajg.0000000000002143.
    PubMed     Abstract available
    
    
    
92. ADEJUMO A, Noll A, Rogal SS, Yakovchenko V, et al
    Dementia frequently co-exists with hepatic encephalopathy but not other cirrhosis complications in US Veterans.
    Am J Gastroenterol. 2023 Jan 17. doi: 10.14309/ajg.0000000000002189.
    PubMed     Abstract available
    
    
    
93. ZHAO Y, Yeo YH, Samaan J, Lv F, et al
    Racial and ethnic disparities in years of potential life loss among patients with cirrhosis during the COVID-19 pandemic in the United States.
    Am J Gastroenterol. 2023 Jan 13. doi: 10.14309/ajg.0000000000002191.
    PubMed    
    
    
    
94. YANG J, Choi WM, Shim JH, Lee D, et al
    Low level of hepatitis B viremia compared with undetectable viremia increases the risk of hepatocellular carcinoma in patients with untreated compensated cirrhosis.
    Am J Gastroenterol. 2023 Jan 9. doi: 10.14309/ajg.0000000000002181.
    PubMed     Abstract available
    
    
    
95. DE VEER RC, van Hooff MC, Corpechot C, Thorburn D, et al
    Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2023 Jan 9. doi: 10.14309/ajg.0000000000002128.
    PubMed     Abstract available
    
    
    
96. JUNG J, Nguyen MH
    Liver-Related Mortality in Hepatitis B Virus Core Antibody+/Hepatitis B Virus Surface Antigen- Patients: Occult Hepatitis B Virus, Hepatitis B Virus Reactivation, and Hepatocellular Carcinoma Development.
    Am J Gastroenterol. 2023;118:24-25.
    PubMed     Abstract available
    
    
    December 2022
97. JIRAPINYO P, Zucker SD, Thompson CC
    Regression of Hepatic Fibrosis Following Endoscopic Gastric Plication in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2022 Dec 23. doi: 10.14309/ajg.0000000000002087.
    PubMed     Abstract available
    
    
    November 2022
98. MATCHETT CL, Rattan P, McConnell JP, Donato LJ, et al
    Chylous Ascites: Reassessment of Diagnostic Criteria in Patients With Portal Hypertension.
    Am J Gastroenterol. 2022 Nov 16. pii: 00000434-990000000-00561.
    PubMed     Abstract available
    
    
    
99. KRAMER JR, Cao Y, Li L, Smith D, et al
    Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection.
    Am J Gastroenterol. 2022;117:1834-1844.
    PubMed     Abstract available
    
    
    October 2022
100. LEE CM, Yoon EL, Nakajima A, Yoneda M, et al
     A Reappraisal of the Diagnostic Performance of B-Mode Ultrasonography for Mild Liver Steatosis.
     Am J Gastroenterol. 2022 Oct 31. pii: 00000434-990000000-00515.
     PubMed     Abstract available
     
     
     
101. CARUSO S, Miraglia R, Alonzo L, Farinella M, et al
     A Rare Portopulmonary Arteriovenous Fistula in a Cirrhotic Patient with Portal Hypertension and Inversion of Blood Flow after Liver Transplantation.
     Am J Gastroenterol. 2022 Oct 6. pii: 00000434-990000000-00541.
     PubMed    
     
     
     
102. REAU N, Munoz SJ, Schiano T
     Liver Disease During Pregnancy.
     Am J Gastroenterol. 2022;117.
     PubMed    
     
     
     
103. HE K, Guo LL, Tang H, Peng X, et al
     A Freshwater Fish-Based Diet Alleviates Liver Steatosis by Modulating Gut Microbiota and Metabolites: A Clinical Randomized Controlled Trial in Chinese Participants With Nonalcoholic Fatty Liver Disease.
     Am J Gastroenterol. 2022;117:1621-1631.
     PubMed     Abstract available
     
     
     
104. JAMALI T, Raasikh T, Bustamante G, Sisson A, et al
     Outcomes of Exercise Interventions in Patients With Advanced Liver Disease: A Systematic Review of Randomized Clinical Trials.
     Am J Gastroenterol. 2022;117:1614-1620.
     PubMed     Abstract available
     
     
     
105. LIU C, Cao Z, Yan H, Wong YJ, et al
     A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study.
     Am J Gastroenterol. 2022;117:1605-1613.
     PubMed     Abstract available
     
     
     
106. LIAO KF, Hwang BF, Liu CS, Lai SW, et al
     Aspirin Use and the Risk of Liver Cancer.
     Am J Gastroenterol. 2022;117:1718.
     PubMed    
     
     
     
107. DEVARBHAVI H, Kurien SS, Raj S, Patil M, et al
     Idiosyncratic Drug-Induced Liver Injury Associated With and Without Drug Reaction With Eosinophilia and Systemic Symptoms.
     Am J Gastroenterol. 2022;117:1709-1713.
     PubMed     Abstract available
     
     
     September 2022
108. CAILES DB, Farouque AO, Majumdar AA, Koshy DAN, et al
     Title: Cardiac Dysfunction in the Pathogenesis of Hepatorenal Syndrome.
     Am J Gastroenterol. 2022 Sep 30. pii: 00000434-990000000-00535.
     PubMed    
     
     
     
109. LIN TAY PW, Ng CH, Lin SY, Chin YH, et al
     Placebo Adverse Events in Non-Alcoholic Steatohepatitis Clinical Trials. A Pooled Analysis of 2,944 Participants.
     Am J Gastroenterol. 2022 Sep 30. pii: 00000434-990000000-00528.
     PubMed     Abstract available
     
     
     
110. SERPER M, Tapper EB, Kaplan DE, Taddei TH, et al
     Patterns of Care Utilization and Hepatocellular Carcinoma Surveillance: Tracking Care Across the Pandemic.
     Am J Gastroenterol. 2022 Sep 16. pii: 00000434-990000000-00513.
     PubMed     Abstract available
     
     
     
111. GUPTA A, Rana R, Agarwal S, Sharma S, et al
     Assessing the risk of further decompensation and survival in patients with cirrhosis with variceal bleeding as their first decompensation event.
     Am J Gastroenterol. 2022 Sep 16. pii: 00000434-990000000-00510.
     PubMed     Abstract available
     
     
     
112. SINGAL AG, Reig M, Villanueva A
     Emerging Tools for Hepatocellular Carcinoma Surveillance.
     Am J Gastroenterol. 2022 Sep 16. pii: 00000434-990000000-00505.
     PubMed    
     
     
     
113. ZACCHERINI G, Baldassarre M, Tufoni M, Nardelli S, et al
     Correction and prevention of hyponatremia in patients with cirrhosis and ascites - Post hoc analysis of the ANSWER study database.
     Am J Gastroenterol. 2022 Sep 6. pii: 00000434-990000000-00502.
     PubMed     Abstract available
     
     
     
114. HAYASHI PH, Lucena MI, Fontana RJ
     RECAM: A New and Improved, Computerized Causality Assessment Tool for DILI Diagnosis.
     Am J Gastroenterol. 2022;117:1387-1389.
     PubMed    
     
     
     
115. TAO Z, Wang H, Du Z, Zhang Y, et al
     Anorectal Variceal Bleeding Treated by Sclerotherapy.
     Am J Gastroenterol. 2022;117:1403.
     PubMed    
     
     
     
116. FAN L, Zhu X, Shingina A, Kabagambe EK, et al
     Racial Disparities in Associations of Alcohol Consumption With Liver Disease Mortality in a Predominantly Low-Income Population: A Report From the Southern Community Cohort Study.
     Am J Gastroenterol. 2022;117:1523-1529.
     PubMed     Abstract available
     
     
     
117. HERCUN J, Noureddin M, Noureddin N, Eccleston J, et al
     Longitudinal Assessment of Bile Duct Loss in Primary Biliary Cholangitis.
     Am J Gastroenterol. 2022 Sep 1. pii: 00000434-990000000-00493.
     PubMed     Abstract available
     
     
     August 2022
118. RAHAL HK, Tabibian JH, Issaka RB, Quezada S, et al
     Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand.
     Am J Gastroenterol. 2022 Aug 25. pii: 00000434-990000000-00492.
     PubMed     Abstract available
     
     
     
119. DEUTSCH-LINK S, Moon AM
     The Ongoing Debate of Serum Ammonia Levels in Cirrhosis: The Good, The Bad, and The Ugly.
     Am J Gastroenterol. 2022 Aug 23. pii: 00000434-990000000-00488.
     PubMed     Abstract available
     
     
     
120. WENTWORTH BJ, Henry ZH, Siragy HM
     How I Approach It: Adrenal Insufficiency in Cirrhosis.
     Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00445.
     PubMed    
     
     
     
121. BHAVSAR-BURKE I, Guardiola JJ, Hamade N, Gerke S, et al
     Use of a cirrhosis admission order set improves adherence to quality metrics and may decrease hospital length of stay.
     Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00463.
     PubMed     Abstract available
     
     
     
122. KUTMUTIA R, Tittanegro T, China L, Forrest E, et al
     Evaluating the role of antibiotics in patients admitted to hospital with decompensated cirrhosis: lessons from the ATTIRE trial.
     Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00458.
     PubMed     Abstract available
     
     
     
123. TANDON P, Pidborochynski T, Abraldes JG, Carbonneau M, et al
     The assessment of driving fitness using an on-road driving evaluation in patients with cirrhosis.
     Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00462.
     PubMed     Abstract available
     
     
     
124. WONG F
     The Cardiorenal Connection: Is Cardiac Output the Sole Determinant of Renal Dysfunction in Cirrhosis?
     Am J Gastroenterol. 2022;117:1242-1243.
     PubMed     Abstract available
     
     
     
125. DANIELSEN KV, Wiese S, Busk T, Nabilou P, et al
     Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study.
     Am J Gastroenterol. 2022;117:1269-1278.
     PubMed     Abstract available
     
     
     
126. LONG A, Magrath M, Mihalopoulos M, Rule JA, et al
     Changes in Epidemiology of Acetaminophen Overdoses in an Urban County Hospital After 20 Years.
     Am J Gastroenterol. 2022;117:1324-1328.
     PubMed     Abstract available
     
     
     July 2022
127. PARK D, Houston K, Duong NK, Dharia N, et al
     REDUCTION IN NOSOCOMIAL INFECTIONS IN PATIENTS with CIRRHOSIS DURING THE COVID-19 ERA COMPARED TO PRE-COVID-19: IMPACT OF MASKING AND RESTRICTING VISITATION?
     Am J Gastroenterol. 2022 Jul 21. pii: 00000434-990000000-00442.
     PubMed     Abstract available
     
     
     
128. VUTIEN P, Berry K, Feng Z, VoPham T, et al
     Combining FIB-4 and liver stiffness into the FIB-5, a single model that accurately predicts complications of portal hypertension.
     Am J Gastroenterol. 2022 Jul 15. pii: 00000434-990000000-00435.
     PubMed     Abstract available
     
     
     
129. ASRANI SK, Hall L, Reddy V, Ogola G, et al
     Comorbid chronic diseases and survival in compensated and decompensated cirrhosis: a population-based study.
     Am J Gastroenterol. 2022 Jul 15. pii: 00000434-990000000-00436.
     PubMed     Abstract available
     
     
     June 2022
130. MOON AM, Ioannou GN
     Moving Away from a One-Size-Fits-All Approach to Hepatocellular Carcinoma Surveillance.
     Am J Gastroenterol. 2022 Jun 24. pii: 00000434-990000000-00430.
     PubMed    
     
     
     
131. INNES H, Hamill V, McDonald SA, Hayes PC, et al
     Comparing predicted probability of hepatocellular carcinoma in cirrhosis patients to the general population: an opportunity to improve risk communication?
     Am J Gastroenterol. 2022 Jun 24. pii: 00000434-990000000-00428.
     PubMed     Abstract available
     
     
     
132. CALVARUSO V, Celsam C, D'Ambrosio R, Simone F, et al
     RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
     Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00413.
     PubMed     Abstract available
     
     
     
133. DAJTI E, Ravaioli F, Marasco G, Alemanni LV, et al
     A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease.
     Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00415.
     PubMed     Abstract available
     
     
     
134. BAJAJ JS, Wong F, Kamath PS, Lai JC, et al
     Acute-on-Chronic Liver Failure.
     Am J Gastroenterol. 2022;117:831-834.
     PubMed    
     
     
     
135. SCORLETTI E, Creasy KT, Vujkovic M, Vell M, et al
     Dietary Vitamin E Intake Is Associated With a Reduced Risk of Developing Digestive Diseases and Nonalcoholic Fatty Liver Disease.
     Am J Gastroenterol. 2022;117:927-930.
     PubMed     Abstract available
     
     
     
136. KANN AE, Jepsen P, Madsen LG, Crooks C, et al
     Motivation to Reduce Drinking and Engagement in Alcohol Misuse Treatment in Alcohol-Related Liver Disease: A National Health Survey.
     Am J Gastroenterol. 2022;117:918-922.
     PubMed     Abstract available
     
     
     May 2022
137. ACHANTA CR, Kinhal SV, Imandi V, Singh A, et al
     Motorized Spiral Enteroscope Guided Biliary Intervention for Treatment of Biliary Obstruction in Patient with HepaticoJejunostomy.
     Am J Gastroenterol. 2022 May 9. pii: 00000434-990000000-00372.
     PubMed    
     
     
     
138. CROCOMBE D, Freemantle N, O'Brien A
     Additional Analyses for the Published Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure.
     Am J Gastroenterol. 2022;117:814-815.
     PubMed    
     
     
     
139. MIR BA, Majeed T, Chauhan A
     A New Window to Favorable Outcome in Acute-on-Chronic Liver Failure.
     Am J Gastroenterol. 2022;117:815.
     PubMed    
     
     
     April 2022
140. RASHMI KG, Sahoo J
     Correspondence from Rashmi et al " Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial ".
     Am J Gastroenterol. 2022 Apr 15. pii: 00000434-990000000-00344.
     PubMed    
     
     
     
141. TAPPER EB, Salim N, Baki J, Zhao Z, et al
     Pickle Juice Intervention for Cirrhotic Cramps Reduction: The PICCLES Randomized Controlled Trial.
     Am J Gastroenterol. 2022 Apr 13. pii: 00000434-990000000-00331.
     PubMed     Abstract available
     
     
     
142. YAMASHITA M, Kugiyama T, Takei D, Hara Y, et al
     An Unexpected Case of Fishbone-Induced Liver Abscess Through the Gallbladder.
     Am J Gastroenterol. 2022 Apr 13. pii: 00000434-990000000-00328.
     PubMed    
     
     
     
143. RAO A, Rule JA, Hameed B, Ganger D, et al
     Secular Trends in Severe Idiosyncratic Drug-Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry.
     Am J Gastroenterol. 2022;117:617-626.
     PubMed     Abstract available
     
     
     
144. KULKARNI AV, Tirumalle S, Premkumar M, Kumar K, et al
     Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial.
     Am J Gastroenterol. 2022;117:607-616.
     PubMed     Abstract available
     
     
     March 2022
145. SHAHA S, Gao Y, Huang J, Imbertson E, et al
     Successful Treatment of Superior Mesenteric Artery Syndrome with Percutaneous Endoscopic Gastrojejunostomy in a Sarcopenic Patient with Cirrhosis.
     Am J Gastroenterol. 2022 Mar 28. pii: 00000434-990000000-00308.
     PubMed    
     
     
     
146. LAMMERT C, Toal E, Mathur K, Khungar V, et al
     Large Hepatic Adenomas and Hepatic Adenomatosis: A multicenter study of risk factors, interventions, and complications.
     Am J Gastroenterol. 2022 Mar 23. pii: 00000434-990000000-00302.
     PubMed     Abstract available
     
     
     
147. COSTA MS, Agostinho C, Figueiredo P
     Abdominal Wall Invasion of Hepatocellular Carcinoma.
     Am J Gastroenterol. 2022 Mar 16. pii: 00000434-990000000-00288.
     PubMed    
     
     
     
148. VIEIRA BARBOSA J, Milligan S, Frick A, Broestl J, et al
     Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease.
     Am J Gastroenterol. 2022;117:453-461.
     PubMed     Abstract available
     
     
     
149. DUARTE-ROJO A, Sejdic E
     Artificial Intelligence and the Risk for Intuition Decline in Clinical Medicine.
     Am J Gastroenterol. 2022;117:401-402.
     PubMed     Abstract available
     
     
     
150. LEE HL, Lin MC, Yeh FC, Tsai MK, et al
     Klebsiella pneumoniae Invasive Syndrome With Ventriculitis.
     Am J Gastroenterol. 2022;117:372.
     PubMed    
     
     
     February 2022
151. UFERE NN, Patzer RE, Kavalieratos D, Louissaint J, et al
     Rural-Urban Disparities in Mortality from Cirrhosis in the United States from 1999 to 2019.
     Am J Gastroenterol. 2022 Feb 25. pii: 00000434-990000000-00270.
     PubMed    
     
     
     
152. LEVY MJ, Bendel EC, Bjarnason H, Reisenauer CJ, et al
     Endoscopic Ultrasound Guided Dual Ultrasound Hepatic Cyst Aspiration and Sclerotherapy to Ameliorate Portal Hypertension.
     Am J Gastroenterol. 2022 Feb 17. pii: 00000434-990000000-00261.
     PubMed    
     
     
     
153. LEONTIADIS GI, Longstreth GF
     Evolutionary medicine perspectives: H. pylori, lactose intolerance, and three hypotheses for functional and inflammatory gastrointestinal and hepatobiliary disorders.
     Am J Gastroenterol. 2022 Feb 15. pii: 00000434-990000000-00250.
     PubMed     Abstract available
     
     
     
154. ZHAO Y, Li X, Yang S, Tao Y, et al
     Small-Diameter Drug-Eluting Beads-Based Transarterial Chemoemboli-zation (DEB-TACE) for Treating Patients With Esophageal Cancer With Acute Bleeding.
     Am J Gastroenterol. 2022 Feb 8. pii: 00000434-990000000-00244.
     PubMed    
     
     
     
155. PENG T, Lu H, Deng L, Li Q, et al
     Diffuse intrahepatic bile duct hamartomas.
     Am J Gastroenterol. 2022 Feb 3. pii: 00000434-990000000-00241.
     PubMed    
     
     
     
156. BAJAJ JS, O'Leary JG, Lai JC, Wong F, et al
     Acute-on-Chronic Liver Failure Clinical Guidelines.
     Am J Gastroenterol. 2022;117:225-252.
     PubMed     Abstract available
     
     
     
157. VAN KLEEF LA, Hofman A, Voortman T, de Knegt RJ, et al
     Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study.
     Am J Gastroenterol. 2022;117:311-318.
     PubMed     Abstract available
     
     
     
158. YU S, Pan L, Ma J, Cao H, et al
     The Underlying Cause of Esophageal Variceal Bleeding: Hereditary Thrombophilia.
     Am J Gastroenterol. 2022;117:217.
     PubMed    
     
     
     January 2022
159. YUAN L, Hanlon CL, Terrault N, Alqahtani S, et al
     Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States.
     Am J Gastroenterol. 2022 Jan 27. pii: 00000434-990000000-00229.
     PubMed     Abstract available
     
     
     
160. LOUISSAINT J, Grzyb K, Bashaw L, Mohammad RA, et al
     An Electronic Decision Support Intervention Reduces Readmissions for Patients With Cirrhosis.
     Am J Gastroenterol. 2022 Jan 12. pii: 00000434-990000000-00194.
     PubMed     Abstract available
     
     
     
161. GONZALEZ SA, Velez JCQ
     Board Review Vignette: Lessons Learned in the Management of Hepatorenal Syndrome Type 1 with Terlipressin.
     Am J Gastroenterol. 2022 Jan 5. pii: 00000434-990000000-00198.
     PubMed    
     
     
     December 2021
162. AHN JC, Attia ZI, Rattan P, Mullan AF, et al
     Development of the AI-Cirrhosis-ECG (ACE) Score: An electrocardiogram-based deep learning model in cirrhosis.
     Am J Gastroenterol. 2021 Dec 29. pii: 00000434-990000000-00204.
     PubMed     Abstract available
     
     
     
163. KIM NJ, Rozenberg-Ben-Dror K, Jacob DA, Berry K, et al
     The COVID-19 pandemic highlights opportunities to improve hepatocellular carcinoma screening and diagnosis in a national health system: COVID-19 and HCC screening and diagnosis.
     Am J Gastroenterol. 2021 Dec 29. pii: 00000434-990000000-00201.
     PubMed     Abstract available
     
     
     
164. HUANG AC, Grab J, Flemming JA, Dodge JL, et al
     Pregnancies With Cirrhosis Are Rising and Associated With Adverse Maternal and Perinatal Outcomes.
     Am J Gastroenterol. 2021 Dec 20. pii: 00000434-990000000-00172.
     PubMed     Abstract available
     
     
     
165. VAN DE BRUAENE C, Houthoofd B, De Coninck S
     A Hepatic Change of Mind.
     Am J Gastroenterol. 2021 Dec 20. pii: 00000434-990000000-00169.
     PubMed    
     
     
     
166. CACOUB P, Asselah T
     Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease.
     Am J Gastroenterol. 2021 Dec 16. pii: 00000434-990000000-00166.
     PubMed     Abstract available
     
     
     
167. LV Y, Bai W, Li K, Wang Z, et al
     Correction to: Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
     Am J Gastroenterol. 2021 Dec 9. pii: 00000434-990000000-00159.
     PubMed    
     
     
     
168. LIZAOLA-MAYO BC, Mathur AK, Borad MJ, Jadlowiec CC, et al
     Immunotherapy as a Downstaging Tool for Liver Transplantation in Hepatocellular Carcinoma.
     Am J Gastroenterol. 2021;116:2478-2480.
     PubMed    
     
     
     
169. HARRISON SA, Baum SJ, Gunn NT, Younes ZH, et al
     Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease.
     Am J Gastroenterol. 2021;116:2399-2409.
     PubMed     Abstract available
     
     
     
170. BERK C, Ammar T, Lee BT
     Acute Liver Failure due to Manufactured Alkaline Water: A Case Series of "Real Water"-Induced Liver Injury.
     Am J Gastroenterol. 2021;116:2476-2477.
     PubMed    
     
     
     
171. MEDAS R, Garrido I, Coelho R, Macedo G, et al
     Extensive Abdominal Wall Hematoma After Paracentesis.
     Am J Gastroenterol. 2021;116:2325.
     PubMed    
     
     
     November 2021
172. KEHAR M, Griffiths R, Flemming JA
     Increasing Incidence of Cirrhosis Over the Past 2 Decades Among Children in Ontario, Canada.
     Am J Gastroenterol. 2021 Nov 18. pii: 00000434-990000000-00150.
     PubMed     Abstract available
     
     
     
173. DAWOD E, Nieto J, Saab S
     Endoscopic Ultrasound-Guided Liver Biopsy: Where Do We Stand?
     Am J Gastroenterol. 2021 Nov 17. pii: 00000434-990000000-00146.
     PubMed    
     
     
     
174. DUONG NK, Shrestha S, Park D, Shahab O, et al
     Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis.
     Am J Gastroenterol. 2021 Nov 5. pii: 00000434-990000000-00135.
     PubMed     Abstract available
     
     
     
175. YANG D, Zhuang B, Xie X
     Hepatic Angiofibroma of Soft tissue: A Case Report.
     Am J Gastroenterol. 2021 Nov 4. pii: 00000434-990000000-00140.
     PubMed    
     
     
     
176. KIM Y, Chang Y, Kwon MJ, Hong YS, et al
     Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults.
     Am J Gastroenterol. 2021;116:2270-2278.
     PubMed     Abstract available
     
     
     October 2021
177. WEBER S, Gerbes AL
     Ashwagandha-Induced Liver Injury: Self-Reports on Commercial Websites as Useful Adjunct Tools for Causality Assessment.
     Am J Gastroenterol. 2021;116:2151-2152.
     PubMed    
     
     
     
178. GAO X, Gao Y, Ye X, Kang W, et al
     Rare Multiple Liver Lesions With Concentric Circle Pattern.
     Am J Gastroenterol. 2021;116:1979.
     PubMed    
     
     
     
179. LIN FP, Visina JM, Bloomer PM, Dunn MA, et al
     Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease.
     Am J Gastroenterol. 2021;116:2105-2117.
     PubMed     Abstract available
     
     
     
180. BOIKE JR, Mazumder NR, Kolli KP, Ge J, et al
     Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study.
     Am J Gastroenterol. 2021;116:2079-2088.
     PubMed     Abstract available
     
     
     
181. JOHNSON DA
     "Sickeningly Sweet".... High-Fructose Corn Syrup-Caveat Emptor!
     Am J Gastroenterol. 2021;116:1970-1971.
     PubMed    
     
     
     September 2021
182. TRIPATHI PR, Sen Sarma M, Yachha SK, Aggarwal A, et al
     Relative Adrenal Insufficiency in Decompensated Cirrhotic Children: Does It Affect Outcome?
     Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00094.
     PubMed     Abstract available
     
     
     
183. LEE HW, Park SY, Lee YR, Lee H, et al
     Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL.
     Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00096.
     PubMed     Abstract available
     
     
     
184. CHINA L, Freemantle N, Forrest E, Kallis Y, et al
     Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE Trial.
     Am J Gastroenterol. 2021 Sep 9. pii: 00000434-990000000-00104.
     PubMed     Abstract available
     
     
     
185. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
     Development of gastroenterology and transplant hepatology milestones 2.0: a guide for programs, faculty, and fellows.
     Am J Gastroenterol. 2021 Sep 7. pii: 00000434-990000000-00088.
     PubMed    
     
     
     
186. BLOOM PP, Robin J, Xu M, Arvind A, et al
     Hepatic Encephalopathy is Associated With Slow Speech on Objective Assessment.
     Am J Gastroenterol. 2021;116:1950-1953.
     PubMed     Abstract available
     
     
     
187. CASTELLANA M, Donghia R, Guerra V, Procino F, et al
     Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
     Am J Gastroenterol. 2021;116:1833-1841.
     PubMed     Abstract available
     
     
     
188. THULUVATH PJ, Alukal JJ, Zhang T
     A Scoring Model to Predict In-Hospital Mortality in Patients With Budd-Chiari Syndrome.
     Am J Gastroenterol. 2021;116:1905-1912.
     PubMed     Abstract available
     
     
     August 2021
189. SACK JS, Liu AF, Gray M, Roat J, et al
     Association of Terry Nails With Liver Cirrhosis.
     Am J Gastroenterol. 2021 Aug 27. pii: 00000434-990000000-00085.
     PubMed     Abstract available
     
     
     
190. FU XL, Chen HL
     COVID-19 Vaccine for Chronic Gastroenterology and Hepatology Patients: A Need for Better Evidence.
     Am J Gastroenterol. 2021 Aug 17. pii: 00000434-990000000-00073.
     PubMed    
     
     
     
191. RODRIGUEZ M, Gonzalez-Dieguez ML, Varela M, Cadahia V, et al
     Impact of Alcohol Abstinence on the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Cirrhosis.
     Am J Gastroenterol. 2021 Aug 16. pii: 00000434-990000000-00111.
     PubMed     Abstract available
     
     
     
192. SCHNEIDER CV, Fromme M, Schneider KM, Bruns T, et al
     Mortality in Patients With Genetic and Environmental Risk of Liver Disease.
     Am J Gastroenterol. 2021;116:1741-1745.
     PubMed     Abstract available
     
     
     
193. TAGUCHI YV, Snyder DL, Shah JB, Dickson RC, et al
     Deglutition Syncope After Variceal Band Ligation.
     Am J Gastroenterol. 2021;116:1763.
     PubMed    
     
     
     
194. HASHEMIAN M, Merat S, Poustchi H, Jafari E, et al
     Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study.
     Am J Gastroenterol. 2021;116:1667-1675.
     PubMed     Abstract available
     
     
     July 2021
195. MOCTEZUMA-VELAZQUEZ C, Abraldes JG
     Statins and Liver Cancer in Cirrhosis: The Most Relevant Questions Are Still Unanswered.
     Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00051.
     PubMed     Abstract available
     
     
     
196. LABENZ C, Labenz J
     Proton Pump Inhibitors in Patients With Liver Cirrhosis: Evidence to Improve Their Battered Reputation.
     Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00048.
     PubMed    
     
     
     
197. USHIDA K, Shimizu M, Yamamoto Y, Momosaki R, et al
     Strategies to Improve Exercise Adherence in Patients With Cirrhosis.
     Am J Gastroenterol. 2021 Jul 13. pii: 00000434-990000000-00043.
     PubMed    
     
     
     
198. PINYOPORNPANISH K, Al-Yaman W, Butler RS, Carey W, et al
     Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
     Am J Gastroenterol. 2021 Jul 2. pii: 00000434-990000000-00036.
     PubMed     Abstract available
     
     
     
199. MATTOS AZ, Leao GS, Bombassaro IZ, Chiesa T, et al
     Definitions for Acute-on-Chronic Liver Failure: In Dubio Pro Reo.
     Am J Gastroenterol. 2021;116:1550.
     PubMed    
     
     
     
200. VAN J, Aloman C, Reau N
     Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver Disease.
     Am J Gastroenterol. 2021 Jul 1. pii: 00000434-990000000-00032.
     PubMed     Abstract available
     
     
     June 2021
201. JINDAL A, Mukund A
     Management of Portal Vein Thrombosis in Cirrhosis-Need a Closer Look!
     Am J Gastroenterol. 2021 Jun 30. pii: 00000434-990000000-00025.
     PubMed    
     
     
     
202. ZHAI LL, Tang ZG
     Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: Several Confounding Factors.
     Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00016.
     PubMed    
     
     
     
203. REIG A, Alvarez-Navascues C, Vergara M, Gomez-Dominguez E, et al
     Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
     Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00017.
     PubMed     Abstract available
     
     
     
204. ACHARYA C, Nadhem O, Shaw J, Hassouneh R, et al
     Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in Cirrhosis.
     Am J Gastroenterol. 2021 Jun 18. pii: 00000434-990000000-00012.
     PubMed     Abstract available
     
     
     
205. LOUISSAINT J, May FP, Williams S, Tapper EB, et al
     Effective Mentorship as a Means to Recruit, Retain, and Promote Underrepresented Minorities in Academic Gastroenterology and Hepatology.
     Am J Gastroenterol. 2021;116:1110-1113.
     PubMed    
     
     
     
206. CRAVEN LJ, Parvathy SN, Burton JP, Silverman MS, et al
     Response to Ianiro et al.
     Am J Gastroenterol. 2021;116:1361-1362.
     PubMed    
     
     
     
207. IANIRO G, Porcari S, Gasbarrini A, Cammarota G, et al
     Quantity of Donor Stool for Fecal Microbiota Transplantation: The More, the Better?
     Am J Gastroenterol. 2021;116:1360-1361.
     PubMed    
     
     
     
208. BENMASSAOUD A, Tsochatzis E
     Response to Debnath and Rathi.
     Am J Gastroenterol. 2021;116:1358-1359.
     PubMed    
     
     
     
209. DEBNATH P, Rathi P
     Sarcopenia and TIPS: How Best to Measure Muscle Mass.
     Am J Gastroenterol. 2021;116:1358.
     PubMed    
     
     
     
210. WU F, Pahkala K, Juonala M, Jaakkola J, et al
     Childhood and Adulthood Passive Smoking and Nonalcoholic Fatty Liver in Midlife: A 31-year Cohort Study.
     Am J Gastroenterol. 2021;116:1256-1263.
     PubMed     Abstract available
     
     
     May 2021
211. HERNANDEZ-CONDE M, Llop E, Gomez-Pimpollo L, Fernandez Carrillo C, et al
     Adding Branched-Chain Amino Acids to an Enhanced Standard-of-Care Treatment Improves Muscle Mass of Cirrhotic Patients With Sarcopenia: A Placebo-Controlled Trial.
     Am J Gastroenterol. 2021 May 26. pii: 00000434-900000000-98756.
     PubMed     Abstract available
     
     
     
212. FARUQUI S, Okoli FC, Olsen SK, Feldman DM, et al
     Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
     Am J Gastroenterol. 2021 May 17. pii: 00000434-900000000-98779.
     PubMed     Abstract available
     
     
     
213. JOHN BV, Khakoo NS, Schwartz KB, Aitchenson G, et al
     Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.
     Am J Gastroenterol. 2021 May 13. pii: 00000434-900000000-98782.
     PubMed     Abstract available
     
     
     
214. GOET JC, Murillo Perez CF, Harms MH, Floreani A, et al
     A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis.
     Am J Gastroenterol. 2021 May 4. pii: 00000434-900000000-98792.
     PubMed     Abstract available
     
     
     
215. WANG R, Yang L, Hu C, Yan J, et al
     A Tip of the Iceberg on the Mechanism of SARS-CoV-2-Induced Liver Injury.
     Am J Gastroenterol. 2021;116:1097-1098.
     PubMed    
     
     
     
216. BENMASSAOUD A, Tsochatzis E
     Response to Anand and Sharma.
     Am J Gastroenterol. 2021;116:1094-1095.
     PubMed    
     
     
     
217. BJORNSSON HK, Bjornsson ES
     Database Studies on Drug-Induced Liver Injury: The Importance of Causality Assessment.
     Am J Gastroenterol. 2021;116:1090-1091.
     PubMed    
     
     
     
218. CHALASANI NP, Maddur H, Russo MW, Wong RJ, et al
     ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
     Am J Gastroenterol. 2021;116:878-898.
     PubMed     Abstract available
     
     
     
219. VILAR-GOMEZ E, Pirola CJ, Sookoian S, Wilson LA, et al
     Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD.
     Am J Gastroenterol. 2021;116:994-1006.
     PubMed     Abstract available
     
     
     
220. YATACO ML, Bowman AW, Keaveny AP
     Management of the Incidental Liver Lesion.
     Am J Gastroenterol. 2021;116:855-861.
     PubMed    
     
     
     
221. ESLAM M, Wong GL, Hashem AM, Chan HL, et al
     A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients.
     Am J Gastroenterol. 2021;116:984-993.
     PubMed     Abstract available
     
     
     April 2021
222. GROVER I, Gunjan D, Singh N, Benjamin J, et al
     Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial.
     Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98797.
     PubMed     Abstract available
     
     
     
223. TRAN S, Jeong D, Henry L, Cheung RC, et al
     Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
     Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98796.
     PubMed     Abstract available
     
     
     
224. THORNTON C, Somayaji R, Parkins M, Swain MG, et al
     Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhosis in the United States.
     Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98795.
     PubMed     Abstract available
     
     
     
225. MA C, Qian AS, Nguyen NH, Stukalin I, et al
     Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016.
     Am J Gastroenterol. 2021 Apr 28. doi: 10.14309/ajg.0000000000001292.
     PubMed     Abstract available
     
     
     
226. KAWAGUCHI Y, Hasegawa K, Hagiwara Y, De Bellis M, et al
     Effect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation.
     Am J Gastroenterol. 2021 Apr 21. pii: 00000434-900000000-98811.
     PubMed     Abstract available
     
     
     
227. SERPER M, Reddy KR, Bewtra M, Ahmad N, et al
     COVID-19 Vaccine Perceptions Among Patients With Chronic Disease in a Large Gastroenterology and Hepatology Practice.
     Am J Gastroenterol. 2021 Apr 19. pii: 00000434-900000000-98813.
     PubMed     Abstract available
     
     
     
228. SHARMA S, Saraya A
     Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?
     Am J Gastroenterol. 2021 Apr 9. pii: 00000434-900000000-98829.
     PubMed    
     
     
     
229. KHALILI M, Kleiner DE, King WC, Sterling RK, et al
     Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
     Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98823.
     PubMed     Abstract available
     
     
     
230. SONI D, Roy A, De A, Verma N, et al
     MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?
     Am J Gastroenterol. 2021;116:836-837.
     PubMed    
     
     
     
231. MORTON A
     Measuring Serum Sodium in Cirrhosis: Regarding "Hyponatremia in Cirrhosis: An Update".
     Am J Gastroenterol. 2021;116:835.
     PubMed    
     
     
     
232. PONS M, Augustin S, Scheiner B, Guillaume M, et al
     Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
     Am J Gastroenterol. 2021;116:723-732.
     PubMed     Abstract available
     
     
     
233. LAI JC, Dodge JL, Kappus MR, Wong R, et al
     A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).
     Am J Gastroenterol. 2021;116:717-722.
     PubMed     Abstract available
     
     
     
234. KOTANI K, Uchida-Kobayashi S, Yoshida K, Kawamura E, et al
     Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma.
     Am J Gastroenterol. 2021;116:631.
     PubMed    
     
     
     
235. TAPPER EB
     Finding Common Ground With Our MASQs Off.
     Am J Gastroenterol. 2021;116:837.
     PubMed    
     
     
     
236. ALUKAL JJ, Thuluvath PJ
     Reply to Morton.
     Am J Gastroenterol. 2021;116:835-836.
     PubMed    
     
     
     
237. YAMADA G, Hagiwara Y, Kimura T, Takeuchi Y, et al
     Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals.
     Am J Gastroenterol. 2021;116:733-740.
     PubMed     Abstract available
     
     
     
238. KOK B, McNeely M, Watt M, Tandon P, et al
     Exercise Only Works If You Do It! The Holy Grail of Adherence.
     Am J Gastroenterol. 2021;116:673-674.
     PubMed     Abstract available
     
     
     March 2021
239. ROGAL S, Youk A, Agbalajobi O, Zhang H, et al
     Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
     Am J Gastroenterol. 2021 Mar 30. pii: 00000434-900000000-98834.
     PubMed     Abstract available
     
     
     
240. GIL-GOMEZ A, Ampuero J, Rojas A, Gallego-Duran R, et al
     Development and Validation of a Clinical-Genetic Risk Score to Predict Hepatic Encephalopathy in Patients With Liver Cirrhosis.
     Am J Gastroenterol. 2021 Mar 2. pii: 00000434-900000000-98817.
     PubMed     Abstract available
     
     
     February 2021
241. TAN HK, Teng MLP, Soh AYS, Cheo SHY, et al
     Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
     Am J Gastroenterol. 2021 Feb 1. doi: 10.14309/ajg.0000000000001176.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.